Category: Medical Cannabis News

To alleviate suffering for thousands of Texas patients, Senator Jose Menendez filed Senate Bill 90, a comprehensive and compassionate medical cannabis bill. If passed, Texas would become the 33rd state to offer medical cannabis for qualifying patients. The proposed legislation would increase the number of debilitating medical conditions that qualify for the Texas Compassionate Use Program (T.CUP). Senate Bill 90 would also allow doctors to treat medical cannabis like any other medicine.

It became legal for doctors to prescribe cannabis based drugs on 1 November. But who will be able to issue these products, for what conditions, and what’s the evidence? Nigel Hawkes reports

Canopy hope the UK Home office is paying attention to its press releases ! “Spectrum Cannabis, a wholly-owned subsidiary of Canopy Growth Corporation (TSX: WEED)(NYSE: CGC), joins UK patients, researchers and clinicians in applauding today’s first prescriptions of medicinal cannabis. From today, patients with exceptional clinical need in England, Wales and Scotland will be prescribed cannabis-based medicines by specialist clinicians for the first time.”

Fortune reminds us that GW Pharma now allowed to sell Epidiolex USA wide. This should improve share activity

Leafly reports.. It’s apparently taken a while for word of the move to get to the US. Javier Hesse, a staff writer at the financial website Benzinga who reported the news on Monday, quotes an official government document that suggests the legal change began more than a month ago:

The Department of of Health has announced that Rhode Island families can now access medical marijuana to treat autism. The decision was issued this week after a petition was filed in April to add autism spectrum disorder (ASD) to the list of qualifying conditions for medical marijuana.

The American Medical Marijuana Physicians Association announces its second annual conference will take place Oct. 12-14 at the Hilton Orlando Lake Buena Vista. The AMMPA Annual Conference is one of the largest conferences in the nation dedicated to physician education and the utilization of medical cannabis as an alternative treatment option.

MedMen Enterprises has agreed to acquire multistate medical marijuana company PharmaCann in an all-stock deal valued at $682 million, inking what is believed to be the largest acquisition to date in the U.S. cannabis industry.

The deal will double the number of states where Los Angeles-based MedMen has licenses to operate – expanding the firm’s reach to 12 states with 66 retails stores and 13 cultivation facilities, the company announced Thursday.. Reports MJ Biz Daily

MPP report… On October 4 in Salt Lake City, medical marijuana supporters and opponents announced that they have reached an agreement on a compromise medical marijuana law that will be enacted during a November special session after the 2018 election.

I misspoke. Recreational cannabis is NOT a gateway drug. I thank my colleagues for correcting me.” The tide seems to be turning.

Surprisingly good precis of recent rulings in favor of employees if you need a quick guide.

The 33-page report, summarized below, is available for free download at the bottom of the page.

Three hospitals received products in the latest export says Tilray – Royal Children’s Hospital, Monash Children’s Hospital and Austin Health – via subsidiary Tilray Australia New Zealand Pty Ltd.

Hawaii has continued improving its 18-year-old medical cannabis program, but long wait times for patients and restrictive regulations still limit access, according to advocate Wendy Gibson. Reports Cannabis Business Times

Louisiana’s State Board of Medical Examiners voted 8-1 to remove a cap established in 2016 that limited physicians to 100 medical marijuana patients. People seeking the treatment pushed elimination of the cap, worried they will have difficulty getting the medication when it becomes available later this year, estimated around November.